Related Experiment Video
Updated: Nov 18, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer
Jian Lv1,2, Qinyong Li2, Ruiqiang Ma2
1Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Long noncoding RNA FGD5 antisense RNA 1 (FGD5-AS1) promotes non-small cell lung cancer (NSCLC) progression by regulating the miR-944/MACC1 axis. Silencing FGD5-AS1 inhibits NSCLC cell viability, migration, and invasion, offering a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long noncoding RNAs (lncRNAs) play crucial roles in cancer development.
- The specific role of FGD5 antisense RNA 1 (FGD5-AS1) in non-small cell lung cancer (NSCLC) remains incompletely understood.
- Investigating lncRNAs like FGD5-AS1 is vital for uncovering novel therapeutic strategies in NSCLC.
Purpose of the Study:
- To elucidate the regulatory mechanism of FGD5-AS1 in NSCLC progression.
- To determine the impact of FGD5-AS1 on NSCLC cell viability, migration, and invasion.
- To identify potential therapeutic targets within the FGD5-AS1 regulatory network.
Main Methods:
- Quantitative real-time PCR (QRT-PCR) to assess gene expression levels.
- Cell viability assays (MTT) and migration/invasion assays (Transwell).
- Dual-luciferase reporter assays to confirm molecular interactions; exosome isolation and characterization.
Main Results:
- FGD5-AS1 and MACC1 expression were elevated in NSCLC, while miR-944 was decreased.
- FGD5-AS1 expression correlated significantly with TNM stage and metastasis.
- FGD5-AS1 knockdown reduced NSCLC cell viability, migration, and invasion via the miR-944/MACC1 pathway, also suppressing M2 macrophage polarization.
Conclusions:
- FGD5-AS1 knockdown attenuates NSCLC progression by modulating the miR-944/MACC1 axis.
- The FGD5-AS1/miR-944/MACC1 pathway represents a promising therapeutic target for NSCLC treatment.
- FGD5-AS1 influences the tumor microenvironment, including macrophage polarization, impacting NSCLC progression.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
